scholarly journals Student-led development and evaluation of a community pharmacy-based cardiovascular risk assessment

Author(s):  
Christine Filion-Murphy ◽  
Lyndsey Hands ◽  
Lyndsey Hockham ◽  
Laura Kirkpatrick ◽  
Sinead McNamara ◽  
...  

Robert Gordon University’s key strength is employability (reflecting close liaison with the professions) and courses must therefore offer opportunities for work-based learning, which can be challenging in the current financial climate. This is a particular problem for Pharmacy: opportunities for placement are extremely limited and tend to be focused on the later years of the course. This ‘late and limited’ exposure to practice is thought to be responsible for significant failures in the ability of students and newly-qualified pharmacists to take their knowledge of science and medicines and apply it in the context of solving clinical problems. Furthermore, a lack of engagement with practice makes it difficult for the theoretical learning (especially the underpinning science) to be effectively contextualised, leading to an artificial segregation of the science and practice sections of the course. While pharmacists must be technically capable, success depends on a broader range of non-technical skills, including communication and empathy as well the ability to deal with the unexpected.  Simulation is used as a partial alternative to the practice environment, but there are often vast differences between these highly-managed scenarios and the real situations encountered in practice.  Since there is no ‘ideal’ setting for a pharmacist, students should be educated and trained with an understanding, at the forefront of their minds, of human factors - something which challenges existing course design. Teaching and learning activities must allow students to explore the differences between the ‘ideal’ and ‘real’ clinical environments and to recognise when deviations from the ideal are likely to affect patient safety. This paper discusses a piece of action research by MPharm undergraduate students, exploring ways in which such activities may be developed.  These new activities are based upon an existing cardiovascular risk assessment, currently used to deliver scientific theory and develop technical skills, and involving the identification of modifiable and non-modifiable risk factors and the use of these to calculate the ten-year risk of cardiovascular disease.The approach involved the building of two simulated scenarios, one representing an ‘ideal’ risk assessment and the other reflecting adverse outcomes arising as a result of practice-based problems.  Developing the simulations required an in-depth analysis of factors contributing to outcomes, and a combination of interviews with healthcare professionals and peer-peer focus groups were used to explore this. This paper discusses the challenges and learning points arising from this work, as well as an evaluation of the ways in which the work was used to enhance teaching in the academic session 2013-14.

2005 ◽  
Vol 12 (3) ◽  
pp. 179
Author(s):  
E. Ratto ◽  
G. Leoncini ◽  
F. Viazzi ◽  
V. Vaccaro ◽  
A. Parodi ◽  
...  

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
L Palmieri ◽  
S Vannucchi ◽  
C Lo Noce ◽  
A Di Lonardo ◽  
B Unim ◽  
...  

Abstract Background Italian National Prevention Plan 2005-08 included 10-year cardiovascular risk assessment (10-CR) for the general population aged 35-69 years using the CUORE Project risk score. GPs were encouraged to perform 10-CR and send data to the Cardiovascular Risk Observatory (CRO). Aim To show updated data of the ongoing surveillance system of the 10-CR in the Italian adult population. Methods Data were collected using the cuore.exe software, freely downloadable by GPs from the CUORE Project website (www.cuore.iss.it). The CRO provides a web-platform to compare data on 10-CR and risk factors at regional/national level. For persons examined at least twice, variations in risk factors from baseline to follow-up and 95% confidence intervals (C.I.) were calculated using methods for matched pair samples. Results Up to February 2019, about 3,500 GPs downloaded cuore.exe; about 300,000 CR assessments on about 140,000 persons were sent to CRO. Mean CR was 3.1% in women (W), 8.5% in men (M); 28% of M, 64% of W were at low risk (CR < 3%); 9.9% of M, 0.4% of W were at high risk (CR ≥ 20%); 26% of M, 16% of W were current smokers; 13% of M, 10% of W were diabetic; 33% of hypertensive M, 35% of hypertensive W were under specific treatment. Among those with at least two risk assessments (31% of the sample), 11% shifted to a lower risk class after one year (14% of M, 7% of W). Systolic blood pressure mean levels decreased by 0.6 mmHg (95%-C.I. 0.3-0.8 mmHg), diastolic blood pressure by 0.5 mmHg (0.2-0.7 mmHg), total cholesterol by 4.1 mg/dl (3.0-5.2 mg/dl), smokers prevalence by 3.1% (2.3%-4.0%); HDL-cholesterol increased in W by 0.3 mg/dl (0.1-0.5 mg/dl). Conclusions Data demonstrate that 10-CR assessment can be an effective first step to implement preventive actions in primary care. Individual risk score is a useful tool for GPs to assess CR and promote primary prevention focusing on the adoption of healthy lifestyles. Data can be used to support health policy decision process. Key messages The cuore.exe software, freely downloadable from the CUORE Project website-www.cuore.iss.it, allows GPs to assess the CUORE Project risk score, to collect and to send data to the CVD Risk Observatory. 10 year Cardiovascular Risk assessment in the general adult population can be an effective first step to implement preventive actions in primary care.


Cancers ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1631
Author(s):  
Anna Astarita ◽  
Giulia Mingrone ◽  
Lorenzo Airale ◽  
Fabrizio Vallelonga ◽  
Michele Covella ◽  
...  

Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are available. In this prospective study, the effectiveness of the European Myeloma Network protocol (EMN) in cardiovascular risk assessment was investigated, identifying major predictors of CVAEs. From January 2015 to March 2020, 116 MM patients who had indication for CFZ therapy underwent a baseline evaluation (including blood pressure measurements, echocardiography and arterial stiffness estimation) and were prospectively followed. The median age was 64.53 ± 8.42 years old, 56% male. Five baseline independent predictors of CVAEs were identified: office systolic blood pressure, 24-h blood pressure variability, left ventricular hypertrophy, pulse wave velocity value and global longitudinal strain. The resulting ‘CVAEs risk score’ distinguished a low- and a high-risk group, obtaining a negative predicting value for the high-risk group of 90%. 52 patients (44.9%) experienced one or more CVAEs: 17 (14.7%) had major and 45 (38.7%) had hypertension-related events. In conclusion, CVAEs are frequent and a specific management protocol is crucial. The EMN protocol and the risk score proved to be useful to estimate the baseline risk for CVAEs during CFZ therapy, allowing the identification of higher-risk patients.


Sign in / Sign up

Export Citation Format

Share Document